Drugs / ALDHbr Umbilical Cord Blood Cells
last change Jul 2012 re-read 3 minutes ago

ALDHbr Umbilical Cord Blood Cells

Cell therapy

Developed for
aplastic anemia · bone marrow failure syndrome · immunodeficiency disease · inborn errors of metabolism · myelodysplastic syndrome
Investigated by
Aldagen · Joanne Kurtzberg, MD

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00692926 Oct 2005 → Jul 2012 aplastic anemia, bone marrow failure syndrome, immunodeficiency disease, inborn errors of metabolism +1 Joanne Kurtzberg, MD Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ALDHbr Umbilical Cord Blood Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT00692926 ↗
Modality Cell therapy “transplantation of umbilical cord blood cells” NCT00692926 ↗